Belantamab (Anti-TNFRSF17 / BCMA / CD269)
Product Specifications
CAS Number
2061894-48-0
Synonyms
GSK2857914
SKU
C00145-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS639985-01 5 Sections
Tissue, Section, Human Tumor, Lymph Nodes Tumor, Reactive Hyperplasia of Lymph Node (Paraffin)
Ask
View Details MBS639985-02 5x 5 Sections
Tissue, Section, Human Tumor, Lymph Nodes Tumor, Reactive Hyperplasia of Lymph Node (Paraffin)
Ask
View Details MBS1361656-01 0.02 mg (E-Coli)
Recombinant Arabidopsis thaliana RNA pseudourine synthase 1 (At1g56345)
Ask
View Details 
MBS1361656-02 0.02 mg (Yeast)
Recombinant Arabidopsis thaliana RNA pseudourine synthase 1 (At1g56345)
Ask
View Details MBS1361656-03 0.1 mg (E-Coli)
Recombinant Arabidopsis thaliana RNA pseudourine synthase 1 (At1g56345)
Ask
View Details MBS1361656-04 0.1 mg (Yeast)
Recombinant Arabidopsis thaliana RNA pseudourine synthase 1 (At1g56345)
Ask
View Details